// App-Quantinova.ai

: Predictors and Pathology of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • Y. Dotan

Principal Investigators

  • W. B. Shapiro

  • A. Aneja

  • Z. Hauqing

  • C. A. Dass

  • K. Shenoy

  • F. C. Cordova

  • G. J. Criner

  • A. J. Mamary

Medical Centers

  • Pulmonary and Critical Care Medicine, St. Luke's University Health Network, Bethlehem, PA, United States,

  • Pulmonary and Critical Care Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, United States,

  • Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, PA, United States,

  • Department of Neurology, Temple University Hospital Philadelphia PA United States

  • Department of Neurology, Temple University Hospital Philadelphia PA United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • Pore forming protein

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A